666sek
-1,3 %
Date:2026-01-20Time:18:00:00Latest report:Q3-2025List:First NorthTicker:CRNO B
Market Cap:2 074 msekEnterprise Value:2 181 msekNet Sales:- msekEarnings:-113,3 msekEmployees:0ISIN:SE0008241558

Ratios

10-year key figure history for Cereno Scientific turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Cereno Scientific with index and moving average MA50 and MA200.

Stockprice:6,66
MA50:7,21
MA200:8,55
Price/MA200:-22,2 %
RSI (14):38,3
Price/MA50:-7,7 %

Description

Cereno Scientific is a biotechnology company. The company specializes in drug development for common and rare cardiovascular diseases. The lead drug candidate is being developed for the treatment of the rare disease pulmonary arterial hypertension, as well as for thrombotic indications. In particular, epigenetic modulation is used to develop treatments for needy patients with cardiovascular diseases. Cereno Scientific's headquarters are located in Mölndal.

Pharmaceuticals